Other GCC Countries Mice Model Market (2025-2030)
The Other GCC Countries Mice Model Market was valued at $1.29 Million in 2025 and projected to reach to $1.64 Million by 2030, representing a compound annual growth rate of 4.9%. Other GCC Countries' mice model market is positioned for moderate but consistent expansion over the forecast period.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Other GCC Countries Mice Model Market Trends and Insights
- Other GCC Countries represents a developing segment within the broader GCC region, driven by increasing investment in biomedical research and pharmaceutical development.
- The 4.9% compound annual growth rate reflects growing adoption of preclinical research models across academic institutions and contract research organizations in Other GCC Countries. Other GCC Countries' mice model market is supported by rising healthcare expenditure and expanding research infrastructure throughout the forecast period.
- The region's focus on establishing world-class research facilities and attracting international pharmaceutical partnerships is accelerating demand for standardized laboratory mice.
- Other GCC Countries continues to position itself as an emerging hub for life sciences research, with government initiatives promoting innovation and scientific advancement driving market expansion from 2025 to 2030..
Key Market Statistics
- CAGR (2025-2030) 4.9% CAGR
- Market Size, 2025 ~USD 1.29 Million
- Forecast, 2030 ~USD 1.64 Million
- Country Other GCC Countries
Other GCC Countries Mice Model Market Overview
Steady Regional Growth :
Other GCC Countries' mice model market is projected to grow from $1.29 million in 2025 to $1.64 million by 2030, representing a consistent 4.9% CAGR despite being a smaller segment within the GCC region.
Biomedical Research Expansion :
Increasing government and private sector investments in biomedical research facilities across Other GCC Countries are driving demand for preclinical research models and laboratory infrastructure.
Pharmaceutical Development Hub :
Growing pharmaceutical and biotechnology companies in Other GCC Countries are establishing local R&D operations, creating sustained demand for genetically modified and disease-specific mouse models.
Emerging Market Opportunity :
As a developing segment within the GCC, Other GCC Countries presents untapped potential for market entrants and suppliers looking to establish early presence in a growing biomedical research ecosystem.
Other GCC Countries Mice Model Market Dynamics
- The 4.9% CAGR reflects gradual maturation of the regional biomedical research sector, supported by increased funding for pharmaceutical development and academic research initiatives.
- Government policies promoting life sciences innovation and regional healthcare advancement are creating favorable conditions for market growth. The market's development is characterized by growing adoption of advanced mouse models for drug discovery and disease research.
- While smaller than major GCC hubs, Other GCC Countries is attracting investment from international research organizations and pharmaceutical companies seeking to diversify their preclinical research operations.
- This trend is expected to sustain market momentum through 2030, with opportunities emerging in specialized model development and research outsourcing services..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Other GCC Countries' mice model market is valued at $1.29 million in 2025 and is projected to reach $1.64 million by 2030.
- The market in Other GCC Countries is growing at a CAGR of 4.9%, reflecting moderate but consistent expansion in preclinical research demand.
- Other GCC Countries is leveraging government support and research infrastructure investments to establish itself as a regional life sciences hub.
- Increasing pharmaceutical partnerships and academic research initiatives in Other GCC Countries are key drivers of market growth through 2030.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
Other GCC Countries Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical Companies : Regional and international pharma firms establishing R&D operations in Other GCC Countries need market data to assess preclinical research capacity, supplier availability, and investment requirements for local operations.
- Biotech Research Suppliers : Manufacturers and distributors of laboratory mice, breeding facilities, and research models require Other GCC Countries-specific market intelligence to identify demand patterns and develop localized sales strategies.
- Academic and Research Institutions : Universities and research centers in Other GCC Countries use market data to justify funding requests, benchmark research capabilities, and plan facility expansions aligned with regional growth trends.
- Healthcare Investors : Private equity and venture capital firms evaluating life sciences investments in the GCC region need Other GCC Countries market analysis to assess growth potential and identify promising research-focused opportunities.
- Government and Policy Makers : Regional health authorities and economic development agencies use market intelligence to design biomedical research incentives, allocate healthcare budgets, and develop science and innovation policies for Other GCC Countries.
Key Companies in the Other GCC Countries Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise market valuation for Other GCC Countries ($1.29M in 2025, $1.64M in 2030) with localized CAGR analysis unavailable in global reports, enabling accurate regional budgeting and investment decisions.
- Competitive Entry Strategy : Identify growth opportunities in an emerging market segment before major competitors establish dominance. Early market intelligence on Other GCC Countries helps suppliers and service providers position offerings strategically.
- Regional Investment Insights : Understand biomedical research investment patterns specific to Other GCC Countries, including government funding trends, pharmaceutical company expansion plans, and academic research initiatives driving market demand.
- Supplier and Partnership Mapping : Gain intelligence on local and regional suppliers, research institutions, and pharmaceutical companies operating in Other GCC Countries to identify partnership and distribution opportunities.
- Forecast-Driven Planning : Utilize 5-year forecast data (2025-2030) to develop long-term business strategies, resource allocation plans, and market expansion timelines tailored to Other GCC Countries' growth trajectory.
Frequently asked questions
What is the current market size of mice models in Other GCC Countries?
The mice model market in Other GCC Countries is estimated at $1.29 million in 2025, based on verified market data.
What is the projected market size for Other GCC Countries by 2030?
Other GCC Countries' mice model market is forecast to reach $1.64 million by 2030, representing growth from the 2025 baseline.
What is the CAGR for the mice model market in Other GCC Countries?
The mice model market in Other GCC Countries is expected to grow at a compound annual growth rate of 4.9% between 2025 and 2030.
What factors are driving growth in Other GCC Countries' mice model market?
Growth in Other GCC Countries is driven by increased biomedical research investment, expanding research infrastructure, government support for life sciences, and growing pharmaceutical partnerships.
How does Other GCC Countries compare to the broader GCC region?
Other GCC Countries represents a developing segment within the GCC region, with a 4.9% CAGR reflecting steady market expansion as the region builds research capabilities and attracts international investment.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report